CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE1336.6019.8 (+1.5 %)
PREV CLOSE ( ) 1316.80
OPEN PRICE ( ) 1270.45
BID PRICE (QTY) 1334.55 (10)
OFFER PRICE (QTY) 1336.65 (14)
VOLUME 6187
TODAY'S LOW / HIGH ( )1270.45 1344.70
52 WK LOW / HIGH ( )613.8 1617.8
NSE1341.0024.8 (+1.88 %)
PREV CLOSE( ) 1316.20
OPEN PRICE ( ) 1320.00
BID PRICE (QTY) 1340.70 (23)
OFFER PRICE (QTY) 1342.00 (10)
VOLUME 35885
TODAY'S LOW / HIGH( ) 1307.65 1341.00
52 WK LOW / HIGH ( )612.9 1619.05
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990
Management Info
C C Paarthipan - Chairman Sridhar Ganesan - Managing Director
Registered Office

Address 3rd Floor, “ Ashvich Towers”,No.3, Developed Plots Industrial Estate,Perungudi,
Chennai,
Tamil Nadu-600096

Phone 044-24968000 / 8012772888 / 71148000

Email info@caplinpoint.net

Website www.caplinpoint.net

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE, Chennai
NEWS
16Apr Caplin Point Laboratories’ arm gets fi
Caplin Point Laboratories’ subsidiary company -- Caplin Steriles (Caplin..
16Apr Caplin Point Laboratories informs abou
Caplin Point Laboratories has informed that it enclosed press release re..
28Mar Caplin Point Laboratories’ arm gets US
Caplin Point Laboratories’ subsidiary -- Caplin Steriles has been grante..
28Mar Caplin Point Laboratories gains as its
Caplin Point Laboratories is currently trading at Rs. 1283.80, up by 23...
28Mar Caplin Point Laboratories informs abou
Caplin Point Laboratories has attached a Press Release regarding grant o..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit554.52342.6
Gross Profit 744.3 2931.5
Operating Profit 812.23189.2
Net Sales 1328.35286.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26275.00 (0.70%)
M.Cap (Rs. in Cr)55502.75
Sanofi India (BSE)
 8480.00 (1.00%)
M.Cap (Rs. in Cr)19641.90
Neuland Laboratories (BSE)
 7600.00 (1.07%)
M.Cap (Rs. in Cr)9745.33
Solara Active Pharma (BSE)
 483.35 (14.33%)
M.Cap (Rs. in Cr)1763.28
Mankind Pharma (BSE)
 2334.30 (2.29%)
M.Cap (Rs. in Cr)93439.26
Shareholding Pattern
PROMOTERS 70.62%
NON-INSTITUTION 26.1%
MUTUAL FUNDS/UTI 0.41%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.